Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden-Reference-Cited by-同舟云学术

Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden

Published:2022-06 Issue:6 Volume:22 Page:781-790
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Nordström Peter,Ballin Marcel,Nordström Anna

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference28 articles.

1. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine;Polack;N Engl J Med,2020

2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

3. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey;Lancet,2021

4. mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar;Chemaitelly;Nat Med,2021

5. Effectiveness of COVID-19 vaccines against the B.1.617.2 (delta) variant;Lopez Bernal;N Engl J Med,2021

Cited by 221 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the risk of SARS-CoV-2 reinfection with the Omicron or Delta variant in Wales, UK;PLOS ONE;2024-09-06

2. Data-driven mathematical modeling approaches for COVID-19: A survey;Physics of Life Reviews;2024-09

3. Visualizing of engineered five-helix bundle protein for blocking SARS-CoV-2 variants in live animals;Chemical Engineering Journal;2024-09

4. Asymptomatic infection and disappearance of clinical symptoms of COVID-19 infectors in China 2022–2023: a cross-sectional study;Scientific Reports;2024-08-06

5. Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination;Human Antibodies;2024-07-24